# Nuclide record nct06298916 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct06298916/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct06298916", "NCT06298916" ;
  schema:name "64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer"@en ;
  schema:alternateName "PHANTOM"@en ;
  schema:description "A phase 1/2 trial of 64Cu-LNTH-1363S in sarcomas, oesophageal cancer, gastric & gastro-oesophageal junction cancer, pancreatic ductal adenocarcinoma and colorectal cancer, run by Lantheus Medical Imaging, now recruiting."@en ;
  schema:url <https://nuclide.cc/trials/nct06298916/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06298916> ;
  nuclide:status "recruiting" ;
  nuclide:tag "pipeline", "ctgov-ingest" ;
  nuclide:phase "1/2" ;
  nuclide:related <https://nuclide.cc/isotopes/cu-64/> ;
  nuclide:companies <https://nuclide.cc/companies/lantheus/> .